Document Detail

Expression of cyclooxygenase-2 and its relationship with mismatch repair and microsatellite instability in hereditary nonpolyposis colorectal cancer.
MedLine Citation:
PMID:  21232179     Owner:  NLM     Status:  In-Data-Review    
Objective To investigate cyclooxygenase-2 (COX-2) expression and its relationship with mismatch repair (MMR) protein expression and microsatellite instability (MSI) in hereditary nonpolyposis colorectal cancer (HNPCC). Methods A total of 28 cases of colorectal adenoma and 14 cases of colorectal carcinoma were collected between July 2003 and July 2007 from 33 HNPCC families. Sporadic colorectal adenoma (n=32) and carcinoma patients (n=24) served as controls. With samples of tumor tissues and normal colonic mucosa collected from the patients, the protein expressions of COX-2 and MMR (hMLH1, hMSH2, and hMSH6) were examined with immunohistochemical assay. Frequency of MSI in five standard MSI loci BAT25, BAT26, D2S123, D5S346, and D17S250 were analyzed by means of polymerase chain reaction. Results The rate of COX-2 high-expression was 53.6% (15/28) and 42.9% (6/14) in HNPCC adenoma and carcinoma; 62.5% (20/32) and 91.7% (22/24) in sporadic adenoma and carcinoma, respectively. That rate was lower in HNPCC carcinoma than in sporadic carcinoma (Pü0.05). MMR-deletion rate and percentage of high-frequency MSI (MSI-H) in HNPCC carcinoma were higher than those in sporadic colorectal carcinoma [both 71.4% (10/14) vs. 12.5% (3/24), both Pü0.01]. Among the 10 MMR-deficient HNPCC carcinoma patients, COX-2 low-expression was observed in 8 cases (80.0%), while COX-2 high-expression was observed in all of the 4 MMR-positive HNPCC carcinoma cases (Pü0.05). In comparison to MMR positive HNPCC carcinoma, HNPCC adenoma, and sporadic carcinoma, COX-2 expression was significantly lower in corresponding MMR-deficient cases (all Pü0.05). The rates of COX-2 low-expression in HNPCC adenoma, HNPCC carcinoma, and sporadic carcinoma with MSI-H were significantly higher than those in the cases with microsatellite stability (all Pü0.05). Conclusion COX-2 is expressed at a low level in HNPCC carcinoma, different from the high COX-2 expression in sporadic carcinoma.
Jin Peng; Sheng Jian-Qiu; Zhang Ying-Hui; Li Ai-Qin; Wu Zi-Tao; Li Shi-Rong
Related Documents :
9252699 - Malignant myoepithelioma of the minor salivary glands arising in a pleomorphic adenoma.
21119599 - Ptph1 cooperates with vitamin d receptor to stimulate breast cancer growth through thei...
21452019 - Inhibitors of histone demethylation and histone deacetylation cooperate in regulating g...
21084279 - Brca2 and nucleophosmin coregulate centrosome amplification and form a complex with the...
21113329 - 16 kda prolactin reduces angiogenesis, but not growth of human breast cancer tumors in ...
1059739 - Salivary gland carcinoma of the palate.
9839499 - Axillary node metastasis from t1n0m0 breast cancer: possible avoidance of dissection in...
11368879 - Oestrogen receptors and microsatellite instability in colorectal carcinoma patients.
2495159 - Early detection, diagnosis, and management of oral and oropharyngeal cancer.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Chinese medical sciences journal = Chung-kuo i hsüeh k'o hsüeh tsa chih / Chinese Academy of Medical Sciences     Volume:  25     ISSN:  1001-9294     ISO Abbreviation:  Chin. Med. Sci. J.     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2011-01-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9112559     Medline TA:  Chin Med Sci J     Country:  China    
Other Details:
Languages:  eng     Pagination:  206-10     Citation Subset:  IM    
Department of Gastroenterology, The Military General Hospital of Beijing, Beijing 100700, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Epigenetic repression of SATB1 by Polycomb group protein EZH2 in epithelial cells.
Next Document:  Culture and identification of human amniotic mesenchymal stem cells.